AU Patent

AU2011218756A1 — Medicament delivery device for administration of opioid antagonists including formulations for naloxone

Assigned to kaleo Inc · Expires 2012-09-13 · 14y expired

What this patent protects

Attorney Docket No. INTJ-008/OOUS - 306456-2115 Abstract Medicament delivery devices for administration of opioid antagonists are described herein. In some embodiments, an apparatus includes a housing, a medicament container disposed within the housing and an energy storage membe…

USPTO Abstract

Attorney Docket No. INTJ-008/OOUS - 306456-2115 Abstract Medicament delivery devices for administration of opioid antagonists are described herein. In some embodiments, an apparatus includes a housing, a medicament container disposed within the housing and an energy storage member disposed within the housing. The medicament container is filled with a naloxone composition that includes naloxone or salts thereof, a tonicity-adjusting agent, and a pH adjusting agent, whereby the osmolality of the naloxone composition ranges from about 250-350 mOsm and the pH ranges from about 3-5. The energy storage member is configured to produce a force to deliver the naloxone composition. 1000 1570 F1 1110 __ FlG.2

Drugs covered by this patent

Patent Metadata

Patent number
AU2011218756A1
Jurisdiction
AU
Classification
—
Expires
2012-09-13
Drug substance claim
No
Drug product claim
No
Assignee
kaleo Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.